APA (7th ed.) Citation

Fazekas, G., Martosne-Mendi, R., Jankovics, I., Szilvasy, I., & Vajo, Z. (2009). Cross-Reactive Immunity to Clade 2 Strains of Influenza Virus A Subtype H5N1 Induced in Adults and Elderly Patients by Fluval, a Prototype Pandemic Influenza Virus Vaccine Derived by Reverse Genetics, Formulated with a Phosphate Adjuvant, and Directed to Clade 1 Strains. Clinical and Vaccine Immunology, 16(4), 437-443. https://doi.org/10.1128/CVI.00327-08

Chicago Style (17th ed.) Citation

Fazekas, György, Rita Martosne-Mendi, Istvan Jankovics, Istvan Szilvasy, and Zoltan Vajo. "Cross-Reactive Immunity to Clade 2 Strains of Influenza Virus A Subtype H5N1 Induced in Adults and Elderly Patients by Fluval, a Prototype Pandemic Influenza Virus Vaccine Derived by Reverse Genetics, Formulated with a Phosphate Adjuvant, and Directed to Clade 1 Strains." Clinical and Vaccine Immunology 16, no. 4 (2009): 437-443. https://doi.org/10.1128/CVI.00327-08.

MLA (9th ed.) Citation

Fazekas, György, et al. "Cross-Reactive Immunity to Clade 2 Strains of Influenza Virus A Subtype H5N1 Induced in Adults and Elderly Patients by Fluval, a Prototype Pandemic Influenza Virus Vaccine Derived by Reverse Genetics, Formulated with a Phosphate Adjuvant, and Directed to Clade 1 Strains." Clinical and Vaccine Immunology, vol. 16, no. 4, 2009, pp. 437-443, https://doi.org/10.1128/CVI.00327-08.